BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2163779)

  • 1. Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patients with heart failure.
    Hirooka Y; Takeshita A; Imaizumi T; Suzuki S; Yoshida M; Ando S; Nakamura M
    Circulation; 1990 Jul; 82(1):147-53. PubMed ID: 2163779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure.
    Nakamura M; Arakawa N; Yoshida H; Makita S; Hiramori K
    Circulation; 1994 Sep; 90(3):1210-4. PubMed ID: 8087930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure.
    Schmitt M; Gunaruwan P; Payne N; Taylor J; Lee L; Broadley AJ; Nightingale AK; Cockcroft JR; Struthers AD; Tyberg JV; Frenneaux MP
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):911-7. PubMed ID: 15001459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasodilatory actions of alpha-human atrial natriuretic peptide and high Ca2+ effects in normal man.
    Fujita T; Ito Y; Noda H; Sato Y; Ando K; Kangawa K; Matsuo H
    J Clin Invest; 1987 Sep; 80(3):832-40. PubMed ID: 3040808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasodilating actions of calcitonin gene-related peptide in normal man: comparison with atrial natriuretic peptide.
    Ando K; Ito Y; Ogata E; Fujita T
    Am Heart J; 1992 Jan; 123(1):111-6. PubMed ID: 1530893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial and venous effects of atrial natriuretic peptide in the human forearm.
    Doorenbos CJ; Blauw GJ; van Brummelen P
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):333-40. PubMed ID: 1829369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure.
    Nakamura M; Arakawa N; Yoshida H; Makita S; Niinuma H; Hiramori K
    Am Heart J; 1998 Mar; 135(3):414-20. PubMed ID: 9506326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors.
    Katz SD; Schwarz M; Yuen J; LeJemtel TH
    Circulation; 1993 Jul; 88(1):55-61. PubMed ID: 8391403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
    Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
    Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slower onset of vasodilating action of brain natriuretic peptide (BNP) compared to atrial natriuretic peptide (ANP) in human forearm resistant vessels.
    Minami H; Yasu T; Tagawa T; Yamakawa K; Ueda S
    Eur J Clin Pharmacol; 2008 Sep; 64(9):859-62. PubMed ID: 18622600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide increases human capillary filtration and venous distensibility.
    Ando S; Imaizumi T; Harada S; Hirooka Y; Takeshita A
    J Hypertens; 1992 May; 10(5):451-7. PubMed ID: 1317906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of brain natriuretic peptide on forearm vasculature: comparison with atrial natriuretic peptide.
    van der Zander K; Houben AJ; Kroon AA; de Leeuw PW
    Cardiovasc Res; 1999 Dec; 44(3):595-600. PubMed ID: 10690292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular responses to local atrial natriuretic peptide infusion in man.
    Webb DJ; Benjamin N; Allen MJ; Brown J; O'Flynn M; Cockcroft JR
    Br J Clin Pharmacol; 1988 Sep; 26(3):245-51. PubMed ID: 2972307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial natriuretic peptide regulates regional vascular volume and venous tone in humans.
    Schmitt M; Broadley AJ; Nightingale AK; Payne N; Gunaruwan P; Taylor J; Lee L; Cockcroft J; Struthers AD; Frenneaux MP
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1833-8. PubMed ID: 12842844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide augments forearm capillary filtration in humans.
    Groban L; Cowley AW; Ebert TJ
    Am J Physiol; 1990 Jul; 259(1 Pt 2):H258-63. PubMed ID: 2142858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma levels of atrial natriuretic peptide, cyclic guanosine monophosphate and renin following 7.5% NaCl + 6% hydroxyethyl starch or Ringer's lactate. A comparative study of 6 normal subjects].
    Furtwängler W; Balogh D; Pomaroli A; Koller J; Wieser C; Mair P
    Anaesthesist; 1990 Oct; 39(10):499-504. PubMed ID: 1703729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic factor attenuates sympathetic reflexes during lower body negative pressure in normal men.
    Kubo SH; Rector TS; Heifetz SM; Sato H; Cohn JN
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):881-9. PubMed ID: 1704979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide-mediated vasodilatory effect of atrial natriuretic peptide in forearm vessels of healthy humans.
    Sugamori T; Ishibashi Y; Shimada T; Sakane T; Takahashi N; Ohata S; Kodani N; Kunizawa Y; Inoue S; Ohta Y; Nakamura K; Shimizu H; Katoh H; Murakami Y
    Clin Exp Pharmacol Physiol; 2002; 29(1-2):92-7. PubMed ID: 11906465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased skeletal muscle vasodilation in patients with congestive heart failure.
    Imaizumi T; Hirooka Y; Takeshita A
    Jpn Circ J; 1992 May; 56(5):500-3. PubMed ID: 1534858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct effect of alpha-human atrial natriuretic peptide on human vasculature in vivo and in vitro.
    Hughes A; Thom S; Goldberg P; Martin G; Sever P
    Clin Sci (Lond); 1988 Feb; 74(2):207-11. PubMed ID: 2962803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.